NASDAQ$ENVX
Enovix Corporation · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
Enovix reported Q1 2025 revenue of $5.1M, a net loss of $23.5M.
For Q1 2025, Enovix reported Revenue was $5.1M, net loss was $23.5M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $5.1M for Q1 2025.
- Net loss $23.5M.
- MD&A highlights operating priorities, liquidity, and sector risks.
Headline financials
Revenue & EPS history
Enovix · Revenue · Quarterly
$5.1M
Forward guidance
Growth healthcare outlook emphasizes clinical adoption, reimbursement, and cash runway.
Tailwinds
- Test volume or device adoption milestones.
- Partnership and pipeline progress.
Headwinds
- Operating losses and R&D spend.
- Reimbursement and competitive pressure.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2025
+1.6%
Avg return
Earnings day
+0.9%
Avg return
5 days after
+3.5%
Avg return
30 days after
52%
11 / 21 earnings
Positive
+51.3%
Q1 2024
Best reaction
-44.2%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.4% | -14.9% | -4.6% | |
| Q4 2025 | -3.3% | -17.6% | -15.0% | |
| Q3 2025 | +0.7% | +4.5% | -33.3% | |
| Q1 2025 | -8.4% | -9.1% | +13.7% | |
| Q4 2024 | +2.6% | -15.6% | -24.5% | |
| Q3 2024 | -8.2% | -20.8% | -19.1% | |
| Q2 2024 | -17.4% | -19.2% | -32.5% | |
| Q1 2024 | +51.3% | +56.2% | +69.6% | |
| Q4 2023 | -12.3% | -22.0% | -29.1% | |
| Q3 2023 | +15.3% | +2.5% | +10.7% | |
| Q2 2023 | -2.0% | +13.1% | -26.8% | |
| Q1 2023 | -16.8% | -13.7% | -4.3% | |
| Q4 2022 | +16.3% | +7.7% | +41.0% | |
| Q3 2022 | -44.2% | -43.1% | -34.9% | |
| Q2 2022 | +46.6% | +72.3% | +46.1% | |
| Q1 2022 | +3.3% | +3.1% | +46.2% | |
| Q3 2020 | +4.6% | +6.0% | -21.5% | |
| Q3 2021 | +0.5% | +14.3% | +12.3% | |
| Q4 2020 | -5.8% | -4.1% | +11.0% | |
| Q2 2021 | -4.8% | -3.8% | +7.9% | |
| Q1 2021 | +12.1% | +23.8% | +60.7% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro